AUS
NZ
UK
CA
USA
FRA
GER
ESP
ITA
NLD
PRT
SWE
GRC
IND
POL
BRA
ZAF
RUS
CHN
UAE
Highlights
The Australian share market has shown early strength, particularly within the energy sector, with key benchmarks including the ASX 200 and All Ordinaries trending higher during the morning session. The performance aligns with upward movement in oil prices and strong momentum across oil, gas, and uranium-related stocks.
Santos (ASX:STO) Draws Market Attention
Santos (ASX:STO), a major player in the oil and gas segment, saw heightened interest following confirmation of a non-indicative proposal from a consortium involving Abu Dhabi’s national oil entity. The proposal has led to the granting of due diligence access. The stock featured prominently in early movements on the ASX 200 index, contributing to the energy sector's broad advance.
Uranium Stocks Record Broad Momentum
The uranium segment also registered significant early session gains. Deep Yellow (ASX:DYL), Paladin Energy (ASX:PDN), Boss Energy (ASX:BOE), and Bannerman Energy (ASX:BMN) each marked substantial upward movement in price during the morning hours. These companies are commonly tracked on the All Ordinaries, and their rise has further bolstered sentiment within the broader energy space.
Technology and Healthcare Names Also Move
Tech and biotech-related names also showed early traction. Amplia Therapeutics (ASX:ATX) saw sharp gains following updates on its ACCENT trial focused on pancreatic cancer. The trial involves the company’s FAK inhibitor narmafotinib used alongside traditional chemotherapies. The developments place Amplia among the notable early gainers on the All Ordinaries.
Contract Development Supports Archtis (ASX:AR9)
Archtis (ASX:AR9) experienced early gains as well, after announcing a software contract with the US Department of Defense. The deal involves deploying the NC Protect platform, and initial rollout is expected to extend to more users. This development positions Archtis as a key tech mover on the All Ordinaries.
Resource Stocks See Exploration Updates
Resource-focused companies such as Tempest Minerals (ASX:TEM) and Redcastle Resources (ASX:RC1) also showed early movement. Tempest highlighted updated test results from its Yalgoo project, emphasizing the quality of iron ore concentrate. Meanwhile, Redcastle disclosed a memorandum of understanding with a contract miner for gold extraction across key projects, supporting its presence on the All Ordinaries index.
Amplia Therapeutics (ASX:ATX) Reports Clinical Milestone
The biotech segment found further momentum with Amplia Therapeutics (ASX:ATX), which disclosed a pathological complete response in a patient enrolled in its cancer drug trial. The news provided a lift to sentiment around the company, driving increased volume and visibility across healthcare watchlists.
Pacgold (ASX:PGO) Extends Gold Intersections
Pacgold (ASX:PGO) recorded movement after reporting drill results from its Alice River project. The exploration results include broad intersections of gold mineralisation at relatively shallow depths. As a result, Pacgold joined the cluster of resource firms showing gains in the morning session on the All Ordinaries.
Redcastle Resources (ASX:RC1) Mining Plan Confirmed
Redcastle Resources (ASX:RC1) gained ground following the announcement of a mining arrangement with a third-party contractor. The deal includes management of extraction processes for gold-bearing zones, while Redcastle retains downstream operational control. The company remains active within the resources segment of the All Ordinaries.
